Characteristics | Number of patients | (%) |
---|---|---|
Age (years) | Â | Â |
  <35 | 1 | (4.0) |
  35-60 | 15 | (60.0) |
  >60 | 9 | (36.0) |
Tumor stage | Â | Â |
  T1-2 | 17 | (69.2) |
  T3 | 4 | (15.4) |
  Tx | 4 | (15.4) |
Nodal stage | Â | Â |
  N0 | 24 | (96.2) |
  N1-x | 1 | (3.80) |
ER | Â | Â |
  Negative | 7 | (28.0) |
  Positive | 18 | (72.0) |
PR | Â | Â |
  Negative | 5 | (25.0) |
  Positive | 20 | (75.0) |
HER-2 | Â | Â |
  Negative | 19 | (76.0) |
  Positive | 6 | (24.0) |
Ki67 | Â | Â |
  <14% | 16 | (64.0) |
  ≥14% | 9 | (36.0) |